Captrust Financial Advisors Eagle Pharmaceuticals, Inc. Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$44.58 - $52.6 $16,628 - $19,619	373 Added 565.15%	439 $22,000
Q4 2021 Feb 14, 2022	BUY	$45.82 - $56.9 $687 - $853	15 Added 29.41%	66 $3,000
Q2 2021 Aug 16, 2021	BUY	$36.86 - $44.5 $331 - $400	9 Added 21.43%	51 $2,000
Q1 2021 May 17, 2021	BUY	$40.32 - $50.97 $685 - $866	17 Added 68.0%	42 $2,000
Q4 2020 Feb 16, 2021	BUY	$41.72 - $51.34 $1,043 - $1,283	25 New	25 $1,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.